Somatotropic axis dysfunction in non-alcoholic fatty liver disease: Beneficial hepatic and systemic effects of hormone supplementation

dc.contributor.authorCabrera, D.
dc.contributor.authorCabello-Verrugio, C.
dc.contributor.authorSolís, N.
dc.contributor.authorMartín, D.S.
dc.contributor.authorCofré, C.
dc.contributor.authorPizarro, M.
dc.contributor.authorArab, J.P.
dc.contributor.authorAbrigo, J.
dc.contributor.authorCampos, F.
dc.contributor.authorIrigoyen, B.
dc.contributor.authorCarrasco-Avino, G.
dc.contributor.authorBezares, K.
dc.contributor.authorRiquelme, V.
dc.contributor.authorRiquelme, A.
dc.contributor.authorArrese, M.
dc.contributor.authorBarrera, F.
dc.date.accessioned2019-05-23T16:08:49Z
dc.date.available2019-05-23T16:08:49Z
dc.date.issued2018-05
dc.descriptionIndexación: Scopus.es_ES
dc.descriptionAcknowledgments: This work was financed by the project FONDECYT #1150311 a F.B.; #11171001 to D.C.; #1150327 to M.A. and #1161646 to C.C.; Comisión Nacional de Investigación Científica y Tecnologica (grant CONICYT PIA/Basal PFB12, Basal Centre for Excellence in Science and Technology to M.A.; Millennium Institute on Immunology and Immunotherapy [P09-016-F], Programa de Cooperación Internacional ECOS-Conicyt [C16S02], UNAB-DI [741-15/N] to C.C. Open access costs were covered by FONDECYT #1150311 a F.B.
dc.description.abstractBackground: Somatotropic axis dysfunction associated with non-alcoholic fatty liver disease (NAFLD) has potential multisystemic detrimental effects. Here, we analysed the effects of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) supplementation on liver histology, adipokine profile and muscle function in an NAFLD model. Methods: C57BL/6 mice were fed with a high fat diet (HFD) for 12 weeks and were separated into three groups treated for 4 weeks with: (1) High fat diet (HFD) (n = 10); (2) HFD + GH 9 μg/g/d (n = 10); (3) HFD + IGF-1 0.02 μg/g/d (n = 9). A control group fed a chow diet was included (n = 6). Liver histology, liver triglycerides content, serum alanine aminotransferase (ALT) activity, adiponectin and leptin serum levels, in vivo muscle strength, tetanic force and muscle fibre cross-sectional area (CSA) were measured. Results: HFD + GH and HFD + IGF-1 groups showed significantly lower ALT activity compared to HFD (p < 0.01). Liver triglyceride content in HFD + GH was decreased compared to HFD (p < 0.01). Histologic steatosis score was increased in HFD and HFD + GH group (p < 0.01), whereas HFD + IGF-1 presented no difference compared to the chow group (p = 0.3). HFD + GH group presented lower serum leptin and adiponectin levels compared to HFD. GH and IGF-1 supplementation therapy reverted HFD-induced reduction in muscle strength and CSA (sarcopenia). Conclusions: GH and IGF-1 supplementation induced significant improvement in liver steatosis, aminotransferases and sarcopenia in a diet-induced NAFLD model. © 2018 by the authors. Licensee MDPI, Basel, Switzerland.es_ES
dc.description.urihttps://www.mdpi.com/1422-0067/19/5/1339
dc.identifier.citationInternational Journal of Molecular Sciences, 19(5), art. no. 1339es_ES
dc.identifier.issn1661-6596
dc.identifier.otherDOI: 10.3390/ijms19051339
dc.identifier.urihttp://repositorio.unab.cl/xmlui/handle/ria/8891
dc.language.isoenes_ES
dc.publisherMDPI AGes_ES
dc.subjectFatty liveres_ES
dc.subjectGrowth hormonees_ES
dc.subjectIGF-1es_ES
dc.subjectInsulin growth factor 1es_ES
dc.subjectSomatotropic axises_ES
dc.titleSomatotropic axis dysfunction in non-alcoholic fatty liver disease: Beneficial hepatic and systemic effects of hormone supplementationes_ES
dc.typeArtículoes_ES
Archivos
Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Cabrera_D_Somatotropic_Axis_Dysfunction.pdf
Tamaño:
13.11 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLES
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción: